Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine.

MLA

Theisen, Michael, et al. “Towards Clinical Development of a Pfs48/45-Based Transmission Blocking Malaria Vaccine.” Expert Review of Vaccines, vol. 16, no. 4, Apr. 2017, pp. 329–36. EBSCOhost, https://doi.org/10.1080/14760584.2017.1276833.

APA

Theisen, M., Jore, M. M., & Sauerwein, R. (2017). Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine. Expert Review of Vaccines, 16(4), 329–336. https://doi.org/10.1080/14760584.2017.1276833

Chicago

Theisen, Michael, Matthijs M Jore, and Robert Sauerwein. 2017. “Towards Clinical Development of a Pfs48/45-Based Transmission Blocking Malaria Vaccine.” Expert Review of Vaccines 16 (4): 329–36. doi:10.1080/14760584.2017.1276833.